184 related articles for article (PubMed ID: 28607805)
1. Simplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients.
Babaei H; Zeinalian M; Emami MH; Hashemzadeh M; Farahani N; Salehi R
Cancer Biol Med; 2017 May; 14(2):142-150. PubMed ID: 28607805
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
[TBL] [Abstract][Full Text] [Related]
3. T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.
Findeisen P; Kloor M; Merx S; Sutter C; Woerner SM; Dostmann N; Benner A; Dondog B; Pawlita M; Dippold W; Wagner R; Gebert J; von Knebel Doeberitz M
Cancer Res; 2005 Sep; 65(18):8072-8. PubMed ID: 16166278
[TBL] [Abstract][Full Text] [Related]
4. CAT25 is a mononucleotide marker to identify HNPCC patients.
Bianchi F; Galizia E; Catalani R; Belvederesi L; Ferretti C; Corradini F; Cellerino R
J Mol Diagn; 2009 May; 11(3):248-52. PubMed ID: 19324995
[TBL] [Abstract][Full Text] [Related]
5. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
7. A Simplified Protocol for Microsatellite Instability Evaluation in Iranian Patients at Risk for Lynch Syndrome.
Abdollahi Z; Tabatabaiefar MA; Noruzi M; Miar P; Kazemi M; Naimi A; Emami MH; Zeinalian M
Lab Med; 2022 May; 53(3):235-241. PubMed ID: 34611695
[TBL] [Abstract][Full Text] [Related]
8. Tumor microsatellite instability and clinicopathologic features in Iranian colorectal cancer patients at risk for Lynch syndrome.
Zeinalian M; Hashemzadeh-Chaleshtori M; Salehi R; Kazemi M; Emami MH
J Res Med Sci; 2015 Feb; 20(2):154-60. PubMed ID: 25983768
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study.
; Müller A; Beckmann C; Westphal G; Bocker Edmonston T; Friedrichs N; Dietmaier W; Brasch FE; Kloor M; Poremba C; Keller G; Aust DE; Fass J; Büttner R; Becker H; Rüschoff J
Int J Colorectal Dis; 2006 Oct; 21(7):632-41. PubMed ID: 16511680
[TBL] [Abstract][Full Text] [Related]
10. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors.
Rasmussen M; Sowter P; Gallon R; Durhuus JA; Hayes C; Andersen O; Nilbert M; Schejbel L; Høgdall E; Santibanez-Koref M; Jackson MS; Burn J; Therkildsen C
Front Oncol; 2023; 13():1147591. PubMed ID: 37143941
[TBL] [Abstract][Full Text] [Related]
12. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.
Vasen HF; Hendriks Y; de Jong AE; van Puijenbroek M; Tops C; Bröcker-Vriends AH; Wijnen JT; Morreau H
Dis Markers; 2004; 20(4-5):207-13. PubMed ID: 15528786
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive duplex MSI test and BAT40 germline polymorphism.
Kang SY; Kim KM
APMIS; 2021 Oct; 129(10):607-615. PubMed ID: 34342050
[TBL] [Abstract][Full Text] [Related]
14. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
16. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
[TBL] [Abstract][Full Text] [Related]
17. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
18. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
19. Development of a fluorescent multiplex assay for detection of MSI-High tumors.
Bacher JW; Flanagan LA; Smalley RL; Nassif NA; Burgart LJ; Halberg RB; Megid WM; Thibodeau SN
Dis Markers; 2004; 20(4-5):237-50. PubMed ID: 15528789
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
